The answer so far

Start with three plain questions: what is the signal, what detects it, and what changes in the cell? The molecular names describe the route, not a guaranteed health benefit.

A signalling pathway is a series or network of molecular events that carries a message from a signal to a change in a cell's behaviour. The molecules involved may come together only briefly. The pathway can amplify a small input, combine it with other inputs, branch into several responses, or be turned down or stopped. A straight line in an illustration is usually a simplification, not a guarantee of the final outcome.124

On this page
  1. Start with signal, receptor and response
  2. Amplification and second messengers
  3. Branches, crosstalk and integration
  4. Timing, location and cell type change the meaning
  5. Read an arrow as a claim—and include the stop signal
  6. Make the relay concrete: EGFR to ERK
  7. Separate observation from explanation
  8. What this helps you ask
  9. Sources
SignalCell responsePathway AProposed linkFOLLOW THE QUESTION

A signal leads to a cell response. The schematic branches toward pathway A and a proposed link, shown with a dashed line.

Conceptual schematic. Simplified and not to scale; not a scan, microscopy image or validated simulation.

Start with signal, receptor and response

A useful first map asks three questions: what is the signal, what detects it, and what changes? The signal may be a hormone, neurotransmitter, growth factor, nutrient or physical cue. When the cue is present, a receptor or sensor changes state. Other molecules inside the cell then pass the message on. These can include adaptor proteins, enzymes, small GTPases, kinases, phosphatases or second messengers. The eventual response might involve an ion channel, metabolism, movement, secretion, gene expression, division or cell death. The exact sequence is a model for the system being studied, not a universal template.12

Amplification and second messengers

A second messenger is a small molecule or ion that carries information within a cell after a receptor detects an outside signal. One activated receptor can stimulate an enzyme that produces many second messenger molecules. Cyclic AMP, calcium, IP3 and diacylglycerol are examples used in different contexts. Each relay step can magnify the original input, helping a cell detect and distribute a signal. Amplification does not guarantee a useful or beneficial outcome: amount, timing, location and the cell's available machinery all matter.23

Branches, crosstalk and integration

Pathways often branch. The same receptor may influence a rapid change in protein activity and a slower change in gene transcription. A cell may also receive several signals at once. Shared enzymes, second messengers or scaffold proteins can let one pathway affect another; this crosstalk can help a cell integrate information but can also make a mechanism claim harder to interpret. Blocking one molecule may alter several routes, and a downstream marker may reflect more than one input.4

Timing, location and cell type change the meaning

Two cells with the same receptor may not respond in the same way. They may express different adaptor proteins, enzymes, transcription factors or feedback regulators. A short pulse can produce a different programme from sustained exposure, and a signal near one membrane compartment can differ from the same messenger elsewhere. State whether evidence comes from a purified assay, cultured cells, an animal model or people. A molecular change in cultured cells does not by itself show that the same pathway explains a clinical outcome.4

Read an arrow as a claim—and include the stop signal

A diagram is a compressed model. An arrow may represent direct activation, an experimentally supported association or a proposed direction of influence. Receptors can be removed from the surface or become less responsive; messengers can be degraded; phosphatases and feedback inhibitors can reduce activity. Termination is part of the pathway. Ask what evidence supports each link, in what setting, and whether the proposed mechanism was connected to an outcome that matters in the organism being studied.14

Make the relay concrete: EGFR to ERK

A growth-factor receptor called EGFR provides one example of a relay. When activated, EGFR gains phosphate tags that help recruit an adaptor protein, Grb2, and an exchange factor, SOS. SOS helps switch on RAS, a molecular switch. RAS can then activate RAF, followed by MEK and ERK: a chain of enzymes called a kinase cascade. A protein kinase adds a phosphate group to another protein; that chemical tag can change the protein’s activity or interactions. Other enzymes, called phosphatases, can remove such tags. This cascade can change protein activity and, in some contexts, gene expression. It is one branch among several EGFR outputs, not a guaranteed instruction for a cell to divide. Cell type, mutations, receptor movement, feedback and enzymes that remove phosphate tags can change the strength and duration of the signal.61

Separate observation from explanation

Measuring a change in one pathway component and a change in a clinical outcome does not by itself establish that the first caused the second. A drug may affect several targets, the pathway marker may be downstream of more than one input, or the laboratory model may not reproduce the tissue context in people. A plausible route explains why a study was designed; an intervention, comparison and relevant outcome are needed to test the competing explanations.15

What this helps you ask

What starts the signal and which receptor detects it? Which intermediate steps were measured rather than inferred? Where could the pathway branch, amplify or receive crosstalk? How was it terminated or adapted to? What cell, tissue, model, dose and time period were studied? Was the mechanism connected to a patient-important outcome or only to a molecular marker?14

Sources, kept close.

Selected supporting sources; this is not a complete literature review.

  1. Signaling pathway — NCI Dictionary of Cancer TermsNational Cancer Institute · Official scientific referenceAccessed 2026-11-03
  2. Strategies of Molecular SignalingNCBI Bookshelf / Neuroscience · Biomedical science referenceAccessed 2026-11-03
  3. Second MessengersNCBI Bookshelf / Neuroscience · Biomedical science referenceAccessed 2026-11-03
  4. General Principles of Cell CommunicationNCBI Bookshelf / Molecular Biology of the Cell · Open biomedical textbook referenceAccessed 2026-11-03
  5. How Do Medicines Work?NIH / NIGMS · Official scientific explainerAccessed 2026-11-03 · Source date: 2023-10-16
  6. Signaling through Enzyme-Linked Cell-Surface ReceptorsNCBI Bookshelf / Molecular Biology of the Cell · Biomedical science textbook referenceAccess checked 2026-11-03 · Inspected for the canonical RTK–RAS–RAF–MEK–ERK relay and its description as a model pathway; used here to explain mechanism, not to imply a universal clinical outcome.

The next useful question.

Foundation

What is a receptor?

A receptor is a protein on or inside a cell that receives a chemical message. Follow the message from binding to cellular response—and keep that mechanism separate from evidence of benefit in people.

6 min read
Research guide

How to read a result.

Keep the outcome, the denominator, the time period and the uncertainty together.

7 min read